Linagliptin and metformin hydrochloride
NDC 72205-407, Linagliptin and metformin hydrochloride, tablet, film coated, from Novadoz Pharmaceuticals LLC.
- Product NDC
- 72205-407
- Status
- Listed
- Labeler
- Novadoz Pharmaceuticals LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208459
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72205-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LINAGLIPTIN2.5 mg/1
- METFORMIN HYDROCHLORIDE500 mg/1
Pharmacologic classes
Biguanide [EPC]; Biguanides [CS]; Dipeptidyl Peptidase 4 Inhibitor [EPC]; Dipeptidyl Peptidase 4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72205-407-01 | 72205040701 | 60 TABLET, FILM COATED in 1 BOTTLE (72205-407-01) |
| 72205-407-02 | 72205040702 | 180 TABLET, FILM COATED in 1 BOTTLE (72205-407-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5cff87ef-97f9-4e3c-9e06-fd257f3cb3fb
Use it
Look up 72205-407 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72205-407 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72205-407. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.